These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38300640)

  • 1. Association of Plasma Markers of Alzheimer's Disease, Neurodegeneration, and Neuroinflammation with the Choroid Plexus Integrity in Aging.
    Bouhrara M; Walker KA; R Alisch JS; Gong Z; Mazucanti CH; Lewis A; Moghekar AR; Turek L; Collingham V; Shehadeh N; Fantoni G; Kaileh M; Bergeron CM; Bergeron J; Resnick SM; Egan JM
    Aging Dis; 2024 Jan; ():. PubMed ID: 38300640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in the choroid plexus volume and microstructure are associated with body adiposity.
    Alisch JSR; Egan JM; Bouhrara M
    Front Endocrinol (Lausanne); 2022; 13():984929. PubMed ID: 36313760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Age-Related Differences in the Human Choroid Plexus Volume, Microstructural Integrity, and Blood Perfusion Using Multiparameter Magnetic Resonance Imaging.
    Alisch JSR; Kiely M; Triebswetter C; Alsameen MH; Gong Z; Khattar N; Egan JM; Bouhrara M
    Front Aging Neurosci; 2021; 13():734992. PubMed ID: 34603011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma biomarkers for diagnosis of Alzheimer's disease and prediction of cognitive decline in individuals with mild cognitive impairment.
    Kivisäkk P; Carlyle BC; Sweeney T; Trombetta BA; LaCasse K; El-Mufti L; Tuncali I; Chibnik LB; Das S; Scherzer CR; Johnson KA; Dickerson BC; Gomez-Isla T; Blacker D; Oakley DH; Frosch MP; Hyman BT; Aghvanyan A; Bathala P; Campbell C; Sigal G; Stengelin M; Arnold SE
    Front Neurol; 2023; 14():1069411. PubMed ID: 36937522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI and fluid biomarkers reveal determinants of myelin and axonal loss with aging.
    Walker KA; Duggan MR; Gong Z; Dark HE; Laporte JP; Faulkner ME; An Y; Lewis A; Moghekar AR; Resnick SM; Bouhrara M
    Ann Clin Transl Neurol; 2023 Mar; 10(3):397-407. PubMed ID: 36762407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease.
    Moscoso A; Grothe MJ; Ashton NJ; Karikari TK; Lantero Rodríguez J; Snellman A; Suárez-Calvet M; Blennow K; Zetterberg H; Schöll M;
    JAMA Neurol; 2021 Apr; 78(4):396-406. PubMed ID: 33427873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's Disease Plasma Biomarkers Distinguish Clinical Diagnostic Groups in Memory Clinic Patients.
    Gerards M; Schild AK; Meiberth D; Rostamzadeh A; Vehreschild JJ; Wingen-Heimann S; Johannis W; Martino Adami P; Onur OA; Ramirez A; Karikari TK; Ashton NJ; Zetterberg H; Blennow K; Maier F; Jessen F
    Dement Geriatr Cogn Disord; 2022; 51(2):182-192. PubMed ID: 35504263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma neurofilament light levels correlate with white matter damage prior to Alzheimer's disease: results from ADNI.
    Nabizadeh F; Balabandian M; Rostami MR; Kankam SB; Ranjbaran F; Pourhamzeh M;
    Aging Clin Exp Res; 2022 Oct; 34(10):2363-2372. PubMed ID: 35226303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of Neurodegeneration Biomarkers in Cerebrospinal Fluid with Markers of Alzheimer's Disease and Vascular Pathology.
    Shir D; Mielke MM; Hofrenning EI; Lesnick TG; Knopman DS; Petersen RC; Jack CR; Algeciras-Schimnich A; Vemuri P; Graff-Radford J
    J Alzheimers Dis; 2023; 92(3):887-898. PubMed ID: 36806507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Choroid plexus genes for CSF production and brain homeostasis are altered in Alzheimer's disease.
    Kant S; Stopa EG; Johanson CE; Baird A; Silverberg GD
    Fluids Barriers CNS; 2018 Dec; 15(1):34. PubMed ID: 30541599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma pTau181 predicts cortical brain atrophy in aging and Alzheimer's disease.
    Tissot C; L Benedet A; Therriault J; Pascoal TA; Lussier FZ; Saha-Chaudhuri P; Chamoun M; Savard M; Mathotaarachchi SS; Bezgin G; Wang YT; Fernandez Arias J; Rodriguez JL; Snellman A; Ashton NJ; Karikari TK; Blennow K; Zetterberg H; De Villers-Sidani E; Huot P; Gauthier S; Rosa-Neto P;
    Alzheimers Res Ther; 2021 Mar; 13(1):69. PubMed ID: 33781319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease.
    Benedet AL; Leuzy A; Pascoal TA; Ashton NJ; Mathotaarachchi S; Savard M; Therriault J; Kang MS; Chamoun M; Schöll M; Zimmer ER; Gauthier S; Labbe A; Zetterberg H; Rosa-Neto P; Blennow K;
    Brain; 2020 Dec; 143(12):3793-3804. PubMed ID: 33210117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.
    Mattsson N; Cullen NC; Andreasson U; Zetterberg H; Blennow K
    JAMA Neurol; 2019 Jul; 76(7):791-799. PubMed ID: 31009028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross-sectional and longitudinal study in the AIBL cohort.
    Chatterjee P; Pedrini S; Doecke JD; Thota R; Villemagne VL; Doré V; Singh AK; Wang P; Rainey-Smith S; Fowler C; Taddei K; Sohrabi HR; Molloy MP; Ames D; Maruff P; Rowe CC; Masters CL; Martins RN;
    Alzheimers Dement; 2023 Apr; 19(4):1117-1134. PubMed ID: 36574591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vivo Detection of Changes Related to Cortical Columnar Organization and Neuroinflammation Across the AD Continuum.
    Torso M; Ridgway GR; Hardingham I; Schwarz AJ; Chance SA
    J Prev Alzheimers Dis; 2022; 9(4):769-779. PubMed ID: 36281682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
    Ritchie C; Smailagic N; Noel-Storr AH; Takwoingi Y; Flicker L; Mason SE; McShane R
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD008782. PubMed ID: 24913723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain alterations in the early Alzheimer's continuum with amyloid-β, tau, glial and neurodegeneration CSF markers.
    Salvadó G; Shekari M; Falcon C; Operto G; Milà-Alomà M; Sánchez-Benavides G; Cacciaglia R; Arenaza-Urquijo E; Niñerola-Baizán A; Perissinotti A; Minguillon C; Fauria K; Kollmorgen G; Suridjan I; Molinuevo JL; Zetterberg H; Blennow K; Suárez-Calvet M; Gispert JD;
    Brain Commun; 2022; 4(3):fcac134. PubMed ID: 35702732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTI-125 Reduces Biomarkers of Alzheimer's Disease in Patients.
    Wang HY; Pei Z; Lee KC; Lopez-Brignoni E; Nikolov B; Crowley CA; Marsman MR; Barbier R; Friedmann N; Burns LH
    J Prev Alzheimers Dis; 2020; 7(4):256-264. PubMed ID: 32920628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T2 heterogeneity: a novel marker of microstructural integrity associated with cognitive decline in people with mild cognitive impairment.
    Wearn AR; Nurdal V; Saunders-Jennings E; Knight MJ; Isotalus HK; Dillon S; Tsivos D; Kauppinen RA; Coulthard EJ
    Alzheimers Res Ther; 2020 Sep; 12(1):105. PubMed ID: 32912337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid ceruloplasmin levels predict cognitive decline and brain atrophy in people with underlying β-amyloid pathology.
    Diouf I; Bush AI; Ayton S;
    Neurobiol Dis; 2020 Jun; 139():104810. PubMed ID: 32087292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.